NFKB1 and cancer: Evidence suggests that proinflammatory pathways contribute to cancer initiation and progression, with the levels of biomarkers like NF-κB and proinflammatory cytokines commonly being elevated in chronic inflammatory environments, thereby contributing to carcinogenic transformation [15].